Treatment of Xerostomia by Herbal Preparation
NCT01579877 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2013-05-14
Summary
The aims of this study are to investigate the effect of famous herbal formula extract on xerostomia, and to determine whether this formula affect various xerostomia-related questionnaires, salivary flow rate, residual saliva and salivary tests.
Conditions
- Xerostomia
Interventions
- DIETARY_SUPPLEMENT
-
Herbal extract granule
The herbal extract granule, Yukmijihwang-tang granule, consists of 6 herbs. Ingredients: Rehmanniae Radix, Deoscoreae Radix, Corni Fructus, Hoelen, Alismatis Radix, Paeoniae Radicis Cortex. Dosage and frequency: 1 pack (3g), 3 packs per day (2 hours after morning, afternoon and evening meal)
- DIETARY_SUPPLEMENT
-
Placebo herbal extract granule
The Yukmijihwang-tang\_Placebo has the same form, color and flavor as experimental intervention (Yukmijihwang-tang). The dosage, frequency and duration is also the same as experimental intervention (Yukmijihwang-tang).
Sponsors & Collaborators
-
Korea Health Industry Development Institute
lead OTHER_GOV
Principal Investigators
-
Jinsung Kim, doctorate · Kyung Hee University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
NCT02317172 ·Status: COMPLETED ·Phase: NA
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
Xerostomia in Patients With a Life-limiting Condition or Frailty
NCT05506137 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effects of Using Augmented Reality (AR) System to Train Foreign Care Workers.
NCT05938166 ·Status: RECRUITING ·Phase: NA
-
Effect of Photobiomodulation for Patients With Xerostomia
NCT05336981 ·Status: COMPLETED ·Phase: NA
-
Interest of Auriculotherapy in the Treatment of Xerostomia
NCT04222478 ·Status: RECRUITING ·Phase: NA
-
Interest of the Sialendoscopy Associated With a Local Injection of Corticosteroids in the Treatment of Radio-induced Xerostomia in Comparison With the Hygiene Rules
NCT04584164 ·Status: RECRUITING ·Phase: NA
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
NCT06805448 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
OGT Spray in the Management of Xerostomia in the Elderly
NCT00350350 ·Status: COMPLETED
-
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
NCT00332618 ·Status: COMPLETED
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Chamomile Effect on Xerostomia Associated With End-stage Renal Disease in Elderly
NCT06114797 ·Status: COMPLETED ·Phase: NA
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
NCT06703372 ·Status: COMPLETED ·Phase: NA
-
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Study New Gel for Xerostomia
NCT04184908 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Saliva Substitutes on Dental Hard Tissues in Situ
NCT01165970 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study
NCT04206826 ·Status: COMPLETED ·Phase: NA
-
Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia
NCT05857358 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Pilocarpine in Patients With Xerostomia
NCT02982577 ·Status: UNKNOWN ·Phase: PHASE4
-
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
NCT02066896 ·Status: COMPLETED ·Phase: NA
-
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
NCT03530735 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia
NCT02005328 ·Status: COMPLETED ·Phase: NA
-
Validation of the French Version of the Xerostomia Inventory
NCT03009786 ·Status: COMPLETED